biomateri
use
evalu
clinic
implant
supplement
sever
shortag
avail
human
donor
organ
date
howev
implant
mainli
develop
scaffold
promot
regener
fail
organ
due
old
age
congenit
malform
real
world
howev
infect
immunolog
issu
often
compromis
patient
exampl
bacteri
viral
infect
result
uncontrol
immunopatholog
damag
lead
organ
failur
henc
need
biomateri
implant
promot
regener
also
address
issu
specif
compromis
patient
infect
inflamm
differ
strategi
need
address
regener
organ
damag
infect
inflamm
success
clinic
translat
therefor
real
quest
multifunct
biomateri
combin
properti
combat
infect
modul
inflamm
promot
regener
time
strategi
necessit
inclus
methodolog
manag
cellular
signal
compon
elicit
within
local
microenviron
develop
biomateri
strategi
rang
inclus
materi
intrins
antiinflammatori
properti
synthet
lipid
polym
phosphorylcholin
mpc
silver
nanoparticl
antibacteri
properti
inclus
nanoand
microparticl
biomateri
composit
deliv
activ
drug
present
review
present
exampl
kind
materi
group
along
pro
con
thu
promis
next
gener
strategi
aid
replac
tissueorgan
transplant
integr
smart
programm
platform
need
regen
medicin
applic
creat
andor
restor
normal
function
cell
tissu
level
therefor
utmost
import
develop
integr
biomateri
base
multifunct
biopolym
nanosystem
practic
success
clinic
translat
biomateri
use
evalu
clinic
implant
supplement
sever
shortag
avail
human
donor
organ
date
howev
implant
mainli
develop
scaffold
promot
regener
fail
organ
due
old
age
congenit
malform
real
world
howev
infect
immunolog
issu
often
compromis
patient
exampl
bacteri
viral
infect
result
uncontrol
immunopatholog
damag
lead
organ
failur
henc
need
biomateri
implant
promot
regener
also
address
issu
specif
compromis
patient
infect
inflamm
differ
strategi
need
address
regener
organ
damag
infect
inflamm
success
clinic
translat
therefor
real
quest
multifunct
biomateri
combin
properti
combat
infect
modul
inflamm
promot
regener
time
strategi
necessit
inclus
methodolog
manag
cellular
signal
compon
elicit
within
local
microenviron
develop
biomateri
strategi
rang
inclus
materi
intrins
antiinflammatori
properti
synthet
lipid
polym
phosphorylcholin
mpc
silver
nanoparticl
antibacteri
properti
inclus
nanoand
microparticl
biomateri
composit
deliv
activ
drug
present
review
present
exampl
kind
materi
group
along
pro
con
thu
promis
next
gener
strategi
aid
replac
tissueorgan
transplant
integr
smart
programm
platform
need
regen
medicin
applic
creat
andor
restor
normal
function
cell
tissu
level
therefor
utmost
import
develop
integr
biomateri
base
multifunct
biopolym
nanosystem
practic
success
clinic
translat
introduct
transplant
donor
organ
tissu
often
treatment
avail
patient
endstag
organ
damag
lead
failur
howev
demand
donor
organ
manyfold
higher
suppli
donat
organ
accord
us
depart
health
human
servic
averag
peopl
receiv
organ
transplant
day
other
die
wait
transplant
due
acut
shortag
high
qualitydon
organ
even
donor
organ
avail
problem
graftversushost
diseas
reject
lead
graft
failur
still
need
solv
altern
donor
organ
transplant
use
bioengin
artifici
organ
multicompon
tissu
replac
tissu
engin
regen
medicin
therefor
rapidli
grow
area
stock
vacanti
mani
case
organ
failur
due
congenit
defect
age
howev
infect
caus
virus
bacteria
caus
uncontrol
damag
lead
organ
failur
current
exampl
includ
pandem
sever
acut
respiratori
syndrom
sar
broke
sar
caus
coronaviru
patient
die
otherwis
healthi
young
adult
whose
immun
system
mount
inflammatori
respons
result
destruct
pulmonari
stem
cell
led
death
patient
holm
even
common
influenza
sever
case
upregul
matrix
metalloproteinas
mmp
shown
result
tissu
destruct
variou
organ
wang
et
al
bacteri
infect
often
progress
slower
manner
viral
one
one
area
bacteri
infect
particularli
problemat
chronic
skin
wound
nonheal
ulcer
skin
burn
eye
ulcer
burn
along
infect
also
sourc
inflamm
tissu
destruct
whether
infect
ensu
immunopatholog
mechan
trigger
caus
acut
rapid
organ
destruct
chronic
problem
consider
develop
biomateri
scaffold
implant
target
promot
regener
compromis
condit
also
concern
biomateri
associ
infect
inflamm
review
biomateri
design
use
compromis
patient
inflamm
activ
infect
present
sever
exampl
group
biomateri
taken
research
case
document
within
literatur
biomateri
essenti
foreign
human
bodi
associ
trigger
inflamm
immun
reaction
initi
inflamm
necessari
wound
http
wwworgandonorgovaboutdatahtml
heal
occur
biomateri
contact
host
tissu
milder
irrit
produc
includ
mild
moder
pain
discomfort
itch
inflamm
occur
sever
respons
present
red
heat
swell
pain
defens
respons
occur
degre
resorb
materi
inflamm
becom
problem
becom
prolong
chronic
increas
sever
lead
immunolog
mediat
event
lead
destruct
implant
celltissu
death
review
inflammatori
respons
biomateri
avail
anderson
et
al
slee
et
al
discuss
foreign
materi
introduc
bodi
biomateri
would
also
potenti
sourc
infect
biomateri
made
metal
ceram
polym
routin
clinic
use
link
infect
buhmann
et
al
busscher
et
al
exampl
approxim
death
per
year
report
usa
due
devicerel
infect
urinari
cathet
central
venou
cathet
made
polyurethan
shown
constitut
entri
pathway
bodi
bacteria
ogradi
et
al
bacteria
compet
cell
adher
surfac
biomateri
mani
similar
mechan
attach
cell
except
better
adapt
surviv
nonviabl
surfac
common
bacteri
infect
polymer
biomateri
come
staphylococcu
epidermidi
epidermidi
skin
staphylococcu
aureu
aureu
often
found
metal
biomateri
bacteria
may
resist
antibiot
differ
surfac
express
found
artifici
heart
synthet
vessel
joint
replac
implant
fixat
devic
iv
cathet
urolog
devic
contact
lens
holzapfel
et
al
ceram
metal
rel
resist
infect
imperfect
surfac
microfractur
pathogen
bacteria
establish
coloni
holzapfel
et
al
group
aliphat
polym
polyethylen
polytetrafluoroethylen
polypropylen
also
polyvinyliden
fluorid
select
affin
toward
endotoxin
davi
thu
potenti
facilit
microenviron
tissu
regener
adsorb
endotoxin
howev
due
absenc
hydrophil
ioniz
group
use
directli
biocompat
function
charg
polym
effect
function
group
select
bind
remov
endotoxin
system
one
exampl
posit
charg
acryl
cellulos
deae
qae
function
group
significantli
absorb
endotoxin
hou
zaniewski
could
import
aspect
design
advanc
biomateri
clinic
translat
recent
biomateri
natur
sourc
gain
signific
interest
scaffold
promot
regener
particular
decellular
organ
tissu
obtain
scaffold
compos
extracellular
matrix
ecm
compon
gain
consider
popular
faulk
et
al
scaffold
shown
conduc
regener
howev
either
deriv
human
cadaver
sourc
xenogen
sourc
sourc
carri
risk
pathogen
transmiss
xenogen
scaffold
addit
risk
induc
allerg
inflamm
reaction
bone
allograft
known
transmit
sever
deadli
virus
like
hepat
tuberculosi
tb
human
immunodefici
viru
vincent
similarli
cornea
report
transmit
hepat
b
viru
hbv
rabi
cytomegaloviru
cmv
creutzfeldtjakob
diseas
cjd
herp
simplex
viru
hsv
apart
differ
bacteria
fungi
lee
et
al
furthermor
heart
valv
shown
transmit
tb
hbv
zou
et
al
skin
seroposit
donor
associ
cmv
transmiss
eastlund
therefor
critic
care
appropri
safeti
measur
rigor
screen
requir
process
transplant
decellular
organ
despit
necessari
earli
stage
wound
heal
inflamm
play
major
role
reject
biomateri
implant
dysregul
excess
chronic
inflamm
neg
impact
wound
heal
process
therefor
strategi
modul
excess
inflamm
need
use
biomateri
control
releas
antiinflammatori
therapeut
increas
control
inflamm
possibl
rang
patholog
condit
howev
choic
biomateri
natur
synthet
form
solid
hydrogel
micro
nanoparticl
depend
caus
tissu
locat
inflamm
consider
also
influenc
natur
antiinflammatori
therapeut
incorpor
biomateri
deliv
two
group
biomateri
possess
intrins
antiinflammatori
properti
design
incorpor
antiinflammatori
agent
exampl
group
given
biopolym
particular
polysaccharid
inher
antiinflammatori
properti
exampl
chitosan
linear
polysaccharid
compos
randomli
distribut
link
dglucosamin
nacetyldglucosamin
deriv
crustacean
shell
long
report
antiinflammatori
properti
song
et
al
studi
antiinflammatori
effect
chitosangelatin
hybrid
materi
crosslink
genipin
conclud
antiinflammatori
effect
genipin
could
due
effect
noino
pathway
inhibit
mrna
express
within
activ
macrophag
song
et
al
chitosanbas
materi
believ
antiinflammatori
base
ro
scaveng
properti
je
kim
biopolym
primarili
polysaccharid
plant
mushroom
elsay
et
al
seawe
rodrigu
et
al
park
et
al
examin
antiinflammatori
properti
possibl
futur
test
biomateri
polyethylen
glycol
peg
nanoconjug
deriv
also
shown
possess
antiinflammatori
properti
dobrovolskaia
mcneil
exampl
peg
hybrid
incorpor
peptid
grgdspg
form
hydrogel
antiinflammatori
properti
grgdspgcontain
peptid
report
protect
mous
pancreat
isletderiv
cell
cytokineinduc
cell
death
function
encapsul
cell
peptidecontain
hydrogel
conjunct
receptor
inhibitori
peptid
particularli
effect
protect
islet
cell
su
et
al
integr
antiinflammatori
materi
implant
tecton
patch
made
interpenetr
network
collagen
phosphorylcholin
mpc
three
patient
small
hospitalbas
studi
compassion
use
reveal
materi
abl
stabli
restor
integr
damag
cornea
patient
chronic
ulcer
eros
epithelium
due
stroma
damag
therebi
reliev
patient
pain
discomfort
photophobia
buznyk
et
al
mpc
also
shown
antiinflammatori
properti
system
exampl
mpcpolym
shown
use
oral
care
protect
oral
infect
prevent
adher
periodont
pathogen
succeed
inflammatori
reaction
thu
protect
gingiv
epithelium
maintain
oral
epitheli
function
yumoto
et
al
hyaluron
acid
ha
hydrogel
wide
use
scaffold
promot
regener
report
antiinflammatori
natur
nakamura
et
al
hirabara
et
al
antibodyconjug
ha
hydrogel
shown
reduc
concentr
macrophag
infiltr
appli
burn
wound
turn
reduc
thick
nonviabl
tissu
friedrich
et
al
habas
scaffold
mesenchym
stem
cell
complet
elimin
inflammatori
process
transplant
pig
model
myocardi
infarct
muscari
et
al
reduc
foreign
bodi
reaction
fbr
plasmidencod
virusencapsul
effici
downregul
inflammatori
respons
collagen
scaffold
transplant
subcutan
rat
van
putten
et
al
holladay
et
al
combin
glycosaminoglycan
high
sulfat
hyaluronan
collagen
scaffold
reduc
secret
proinflammatori
cytokin
increas
antiinflammatori
cytokin
macrophag
cultur
implant
kajahn
et
al
vitromimick
condit
steril
tissu
injuri
biomateri
clinic
use
inher
antiinflammatori
natur
howev
use
deliv
wide
varieti
therapeut
agent
develop
control
inflamm
need
deliveri
agent
stem
fact
therapeut
agent
fail
achiev
high
enough
local
concentr
exert
effect
one
approach
address
problem
use
biomateri
deliveri
agent
reservoir
therapeut
agent
particular
provid
sustain
releas
effect
concentr
prolong
period
time
exampl
incorpor
stromal
cellderiv
alpha
plga
scaffold
reduc
inflamm
transplant
subcutan
caviti
balbc
mice
improv
tissu
respons
regen
potenti
tissu
engin
scaffold
reduc
local
inflamm
decreas
number
respons
mast
cell
near
implant
togeth
reduc
express
increas
vegf
express
thevenot
et
al
plla
scaffold
releas
ibuprofen
shown
reduc
express
lead
decreas
inflammatori
respons
improv
muscl
regener
yuan
et
al
dexamethason
incorpor
hydrogel
reduc
express
macrophag
ultim
reduc
inflammatori
respons
lipopolysaccharidestimul
primari
mous
macrophag
vitro
ito
et
al
gelatin
hydrogel
incorpor
mix
immunosuppress
triptolidemicel
bone
morphogen
downregul
express
proand
antiinflammatori
cytokin
includ
reduc
local
inflamm
respons
enhanc
bone
regener
rat
model
ratanavaraporn
et
al
although
plethora
potenti
deliveri
system
report
antiinflammatori
drug
deliveri
materi
current
use
clinic
one
system
sustain
deliveri
dexamethason
ozurdex
allergan
inc
irvin
ca
usa
implant
introduc
posterior
segment
patient
eye
variou
patholog
condit
includ
diabet
macular
edema
noninfecti
intermedi
uveiti
birdshot
chorioretinopathi
shown
exhibit
good
safeti
profil
promis
result
edema
inflamm
control
cao
et
al
dugel
et
al
walsh
reddi
clinic
trial
ongo
confirm
initi
result
clinicaltrialsgov
identifi
like
biomateri
innat
antiinflammatori
behavior
biomateri
intrins
antiinfect
properti
effect
carrier
antibacteri
antivir
agent
bioactiv
develop
combat
infecti
agent
wide
rang
select
exampl
provid
biomateri
contain
sulfat
group
known
antiinfect
properti
includ
antibacteri
well
antivir
properti
bestknown
marinederiv
sulfat
polysaccharid
deriv
brown
seawe
phaeophycea
fucu
laminaria
ascophyllum
macromolecul
includ
algin
fucoidan
berteau
mulloy
marguerit
among
properti
attribut
fucoidan
antivir
activ
damont
et
al
fucoidan
isol
contain
mainli
osulf
also
contain
acetyl
group
type
saccharid
protein
morya
et
al
group
examin
possibl
reproduc
antivir
properti
fucoidan
synthet
mimic
confirm
sulfat
essenti
activ
virus
herp
simplex
viru
serotyp
tengdeliu
et
al
howev
also
found
activ
synthet
fucoidan
similar
sulfat
polysaccharid
heparin
dextran
sulfat
nonsulf
control
synthet
fucoidan
polyacrylamid
block
viral
activ
show
synthet
osulf
fucoidan
block
activ
viral
adsorpt
step
react
viral
particl
prevent
entri
cell
tengdeliu
et
al
recent
examin
efficaci
anoth
fulli
synthet
sulfat
biomateri
polystyren
sulfon
poli
sodium
pss
develop
theranost
contact
lens
ie
contact
lens
could
detect
modul
infect
pss
use
coat
effect
provid
antivir
activ
mak
et
al
wide
rang
nanomateri
carbon
nanotub
cnt
fulleren
dendrim
metal
nanoparticl
shown
intrins
antiinfect
properti
bacteria
virus
pathogen
review
rai
et
al
tabl
provid
list
variou
nanoparticl
system
report
antimicrobi
antibacteri
activ
bestknown
metal
nanoparticl
antibacteri
activ
silver
nanoparticl
agnp
silver
gener
known
antibacteri
antivir
properti
use
silver
medic
implant
long
histori
medic
use
colloid
silver
approv
wound
treatment
sinc
regist
bactericid
substanc
sinc
nowack
et
al
reidi
et
al
new
solut
combin
regener
antimicrobi
effect
allow
faster
safer
recoveri
injuri
silver
contain
wound
dress
includ
acticoat
commerci
wound
dress
util
nanocrystalin
silver
khundkar
et
al
actisorb
contain
silvernylon
cloth
calgitrol
ag
util
silveralgin
simon
et
al
silver
ion
shown
toxic
cell
also
vivo
howev
shown
silver
nanoparticl
produc
nake
particl
coat
collagen
peptid
reduc
cytotox
human
skin
epiderm
cell
compar
ionic
silver
alarcon
et
al
howev
effect
bacteria
test
aureu
strain
attc
epidermidi
strain
escherichia
coli
strain
pseudomona
aeruginosa
strain
methicillinresist
epidermidi
mrse
mahajan
et
al
methicillinresist
aureu
mrsa
report
success
inhibit
nanosilv
embed
bone
cement
vitro
model
human
osteoblast
wherea
similar
cement
gentamicin
could
abl
prevent
infect
resist
strain
alt
et
al
within
group
develop
simpl
composit
collagenbas
hydrogel
includ
silver
nanoparticl
antibacteri
properti
corneal
implant
alarcon
et
al
nanoparticl
differ
composit
also
antivir
activ
tabl
shown
interact
viru
sizedepend
manner
possibl
subunit
viral
envelop
glycoprotein
di
gianvincenzo
et
al
lara
et
al
like
antibiot
howev
resist
silver
found
bacteria
report
date
point
resist
plasmidbas
bacteria
examin
shown
harbor
plasmid
overal
incid
silver
resist
remain
low
compar
antibiot
resist
nanoparticl
also
use
carrier
bioactiv
antivir
drug
exampl
silver
gold
coat
sulfat
ligand
develop
shown
exert
antihiv
activ
inhibit
bind
hiv
host
cell
receptor
earli
stage
viral
replic
di
gianvincenzo
et
al
lara
et
al
sever
studi
evalu
potenti
antivir
efficaci
antivir
drug
deliveri
system
infect
bowman
et
al
mahajan
et
al
chiodo
et
al
bastian
et
al
hbv
show
promis
result
term
enhanc
antivir
potenc
effici
deliveri
drugspeptid
use
zhang
et
al
show
adefovir
dipiroxil
adv
nucleotid
analog
potent
antivir
activ
chronic
hbv
load
solid
lipid
np
significantli
lower
hbv
dna
level
compar
free
adv
zhang
et
al
previous
report
collagen
implant
contain
silica
nanoparticl
releas
peptid
antivir
properti
sophist
composit
biomateri
develop
local
antibiot
carrier
system
offer
regul
releas
antibiot
specif
tissu
implant
exampl
biomateri
nanoparticl
system
compris
particl
photocatalyt
shell
magnet
core
form
remov
antimicrobi
photocatalyst
system
extract
spray
surfac
infect
region
exposur
rana
et
al
biocompat
inject
polymer
carrier
eg
pluron
respond
situ
physiolog
stimuli
also
develop
control
drug
releas
et
al
combat
increas
concern
antibiot
resist
composit
nanosystem
combin
convent
antibiot
nanoparticl
report
success
inhibit
drug
resist
microb
compar
antibiot
alon
campoccia
et
al
sever
approach
go
antibioticload
biomateri
local
infect
prophylaxi
one
exampl
avail
use
clinic
poli
llactid
pdlla
coat
idea
turn
implant
drug
deliveri
devic
summar
differ
function
aspect
major
concern
develop
biomateri
success
clinic
translat
figur
conclus
biomateri
develop
address
issu
infect
inflamm
compromis
patient
includ
materi
inher
antiinflammatori
antiinfect
properti
well
materi
bioengin
deliv
properti
sever
exampl
reach
preclin
clinic
evalu
stage
show
promis
result
howev
area
still
infanc
search
biomateri
implant
promot
regener
address
local
infect
inflamm
continu
hp
mg
conceptu
area
review
mi
je
gp
ob
contribut
respect
section
alarcon
e
udekwu
k
noel
c
w
gagnon
l
b
p
taylor
p
k
vulesev
b
et
al
safeti
efficaci
composit
collagensilv
nanoparticl
hydrogel
tissu
engin
scaffold
nanoscal
alarcon
e
vulesev
b
argaw
ross
bejjani
p
podrebarac
j
et
al
colour
cornea
replac
antiinfect
properti
expand
